FTLF vs. MDWD, BGXX, NAII, CDXC, BTMD, ACB, DBVT, VXRT, SY, and VTGN
Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include MediWound (MDWD), Bright Green (BGXX), Natural Alternatives International (NAII), ChromaDex (CDXC), biote (BTMD), Aurora Cannabis (ACB), DBV Technologies (DBVT), Vaxart (VXRT), So-Young International (SY), and Vistagen Therapeutics (VTGN). These companies are all part of the "medical" sector.
MediWound (NASDAQ:MDWD) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings.
46.8% of MediWound shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 9.2% of MediWound shares are owned by insiders. Comparatively, 61.2% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, FitLife Brands had 1 more articles in the media than MediWound. MarketBeat recorded 1 mentions for FitLife Brands and 0 mentions for MediWound. MediWound's average media sentiment score of 1.43 beat FitLife Brands' score of 0.30 indicating that FitLife Brands is being referred to more favorably in the news media.
MediWound has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.
MediWound presently has a consensus price target of $32.00, suggesting a potential upside of 68.87%. Given FitLife Brands' higher probable upside, research analysts clearly believe MediWound is more favorable than FitLife Brands.
FitLife Brands has a net margin of 10.05% compared to FitLife Brands' net margin of -35.94%. MediWound's return on equity of 27.17% beat FitLife Brands' return on equity.
FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
MediWound received 388 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 62.28% of users gave MediWound an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.
Summary
FitLife Brands beats MediWound on 10 of the 17 factors compared between the two stocks.
Get FitLife Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FitLife Brands Competitors List
Related Companies and Tools
